Real clinical setting intravenous ketamine use for treatment resistant depression: 12 month follow-up after initial response

Rev Psiquiatr Salud Ment (Engl Ed). 2021 Oct-Dec;14(4):227-229. doi: 10.1016/j.rpsmen.2021.11.004.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Treatment-Resistant* / drug therapy
  • Follow-Up Studies
  • Humans
  • Infusions, Intravenous
  • Ketamine* / therapeutic use

Substances

  • Antidepressive Agents
  • Ketamine